65 related articles for article (PubMed ID: 21076641)
41. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.
Tsoumpou I; Arbyn M; Kyrgiou M; Wentzensen N; Koliopoulos G; Martin-Hirsch P; Malamou-Mitsi V; Paraskevaidis E
Cancer Treat Rev; 2009 May; 35(3):210-20. PubMed ID: 19261387
[TBL] [Abstract][Full Text] [Related]
42. Detecting high-grade cervical disease on ASC-H cytology: role of BD ProEx C and Digene Hybrid Capture II HPV DNA testing.
Siddiqui MT; Cohen C; Nassar A
Am J Clin Pathol; 2008 Nov; 130(5):765-70. PubMed ID: 18854269
[TBL] [Abstract][Full Text] [Related]
43. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.
Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; De Marco L; Giorgi-Rossi P; Pontenani G; Rosso S; Sani C; Sintoni C; Segnan N; Zorzi M; Cuzick J; Rizzolo R; Ronco G;
Lancet Oncol; 2008 Oct; 9(10):937-45. PubMed ID: 18783988
[TBL] [Abstract][Full Text] [Related]
44. p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri.
Negri G; Bellisano G; Zannoni GF; Rivasi F; Kasal A; Vittadello F; Antoniazzi S; Faa G; Ambu R; Egarter-Vigl E
Am J Surg Pathol; 2008 Nov; 32(11):1715-20. PubMed ID: 18769337
[TBL] [Abstract][Full Text] [Related]
45. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.
Pinto AP; Schlecht NF; Woo TY; Crum CP; Cibas ES
Mod Pathol; 2008 Sep; 21(9):1067-74. PubMed ID: 18552822
[TBL] [Abstract][Full Text] [Related]
46. Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology.
Beccati MD; Buriani C; Pedriali M; Rossi S; Nenci I
Cancer; 2008 Jun; 114(3):196-203. PubMed ID: 18442059
[TBL] [Abstract][Full Text] [Related]
47. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix.
Badr RE; Walts AE; Chung F; Bose S
Am J Surg Pathol; 2008 Jun; 32(6):899-906. PubMed ID: 18425044
[TBL] [Abstract][Full Text] [Related]
48. Biological behavior of CIN lesions is predictable by multiple parameter logistic regression models.
van Hamont D; Bulten J; Shirango H; Melchers WJ; Massuger LF; de Wilde PC
Carcinogenesis; 2008 Apr; 29(4):840-5. PubMed ID: 18310095
[TBL] [Abstract][Full Text] [Related]
49. p16 and Ki-67 immunostaining in atypical immature squamous metaplasia of the uterine cervix: correlation with human papillomavirus detection.
Iaconis L; Hyjek E; Ellenson LH; Pirog EC
Arch Pathol Lab Med; 2007 Sep; 131(9):1343-9. PubMed ID: 17824788
[TBL] [Abstract][Full Text] [Related]
50. The negative predictive value of p16INK4a to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix.
Hariri J; Øster A
Int J Gynecol Pathol; 2007 Jul; 26(3):223-8. PubMed ID: 17581402
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.
Shi J; Liu H; Wilkerson M; Huang Y; Meschter S; Dupree W; Schuerch C; Lin F
Hum Pathol; 2007 Sep; 38(9):1335-44. PubMed ID: 17512033
[TBL] [Abstract][Full Text] [Related]
52. Redefining early cervical neoplasia: recent progress.
Nucci MR; Crum CP
Adv Anat Pathol; 2007 Jan; 14(1):1-10. PubMed ID: 17198305
[TBL] [Abstract][Full Text] [Related]
53. Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C).
Kelly D; Kincaid E; Fansler Z; Rosenthal DL; Clark DP
Cancer; 2006 Dec; 108(6):494-500. PubMed ID: 17063495
[TBL] [Abstract][Full Text] [Related]
54. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions?
Lorenzato M; Caudroy S; Bronner C; Evrard G; Simon M; Durlach A; Birembaut P; Clavel C
Hum Pathol; 2005 Oct; 36(10):1101-7. PubMed ID: 16226110
[TBL] [Abstract][Full Text] [Related]
55. Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study.
Sahebali S; Depuydt CE; Boulet GA; Arbyn M; Moeneclaey LM; Vereecken AJ; Van Marck EA; Bogers JJ
Int J Cancer; 2006 Mar; 118(5):1254-60. PubMed ID: 16161049
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemistry in assessment of molecular pathogenesis of cervical carcinogenesis.
Syrjänen KJ
Eur J Gynaecol Oncol; 2005; 26(1):5-19. PubMed ID: 15754993
[TBL] [Abstract][Full Text] [Related]
57. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica.
Wang SS; Trunk M; Schiffman M; Herrero R; Sherman ME; Burk RD; Hildesheim A; Bratti MC; Wright T; Rodriguez AC; Chen S; Reichert A; von Knebel Doeberitz C; Ridder R; von Knebel Doeberitz M
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1355-60. PubMed ID: 15298958
[TBL] [Abstract][Full Text] [Related]
58. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study.
Stoler MH; Schiffman M;
JAMA; 2001 Mar; 285(11):1500-5. PubMed ID: 11255427
[TBL] [Abstract][Full Text] [Related]
59. Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
Keating JT; Ince T; Crum CP
Adv Anat Pathol; 2001 Mar; 8(2):83-92. PubMed ID: 11236957
[TBL] [Abstract][Full Text] [Related]
60. Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia?
Park JJ; Sun D; Quade BJ; Flynn C; Sheets EE; Yang A; McKeon F; Crum CP
Am J Surg Pathol; 2000 Oct; 24(10):1414-9. PubMed ID: 11023104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
